Cascade impactor (CI) mensuration-an assessment of the accuracy and precision of commercially available optical measurement systems

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 472-484

  Chambers, Frank ^a   Ali, Aziz ^a   Mitchell, Jolyon ^b   Shelton, Christopher ^c   Nichols, Steve ^d  

^a ASTRAZENECA   (United Kingdom)

^b TRUDELL MEDICAL INTERNATIONAL   (Canada)

^c Pharmaceutical Product Development   (United States)

^d OINDP Consultant   (United Kingdom)

Author keywords

Cascade impactor; Inhaler testing; Optical inspection; Performance verification; Stage mensuration

Indexed keywords

CHROMIUM;

ACCURACY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CASCADE IMPACTOR; CONTROLLED STUDY; PARTICLE SIZE; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL;

AEROSOLS; HUMANS; OPTICAL DEVICES; PARTICLE SIZE; SOLVENTS;

EID: 77950918525     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9405-0     Document Type: Article

References (17)

1. United States Federal Drug Administration (FDA). Draft Guidance: Metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products chemistry, manufacturing and controls documentation. Rockville MD, United States: Federal Drug Administration; 1998. Docket 98D-0997.
2. European Medicines Agency (EMEA). Guideline on the pharmaceutical quality of inhalation and nasal products. London, UK: European Medicines Agency; 2006. EMEA/CHMP/QWP/49313/2005 Final.
3. VA Marple BYH Liu 1974 Characteristics of laminar jet impactors Environ Sci Technol 8 648 654 10.1021/es60092a003 1:CAS:528:DyaE2cXksFertrc%3D
4. Marple VA, Willeke K. Inertial impactors: theory, design and use. In: Liu BYH, editor. Fine particles. NY: Academic Press; 1976. p. 411-66.
5. JP Mitchell MW Nagel 2003 Cascade impactors for the size characterization of aerosols from medical inhalers; their uses and limitation J Aerosol Med 16 341 376 10.1089/089426803772455622 1:CAS:528:DC%2BD2cXltFagtw%3D%3D 14977427 (Pubitemid 38120942)
6. Nichols SC. Particle size distribution parameters using the next generation pharmaceutical impactor. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, editors. Respiratory drug delivery-IX. River Grove: Davis Healthcare Int. Publ; 2004. p. 485-7.
7. Mitchell JP, Roberts DL, Chambers F, Aziz A, Shelton C, Nichols S. Cascade impactor calibration, mensuration and in-use qualification methods: a practical guide. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young P. Respiratory Drug Delivery 2010, Davis Healthcare Int. Publ., River Grove, IL, (in press)
8. RN Berglund BYH Liu 1973 Generation of monodisperse aerosol standards Environ Sci Technol 7 147 153 10.1021/es60074a001 1:CAS:528:DyaE3sXnsFGjug%3D%3D
9. BYH Liu DYH Pui 1974 A sub-micron aerosol standard and the primary calibration of the condensation nucleus counter J. Colloid Interface Sci 47 155 171 10.1016/0021-9797(74)90090-3 1:CAS:528:DyaE2cXksFCltbw%3D
10. Copley M. The importance of stage mensuration in cascade impaction. Pharm. Technol. Europe. Sept. 2008. Available at: http://www.ptemag.com/ pharmtecheurope/analytical+equipment/The-importance-of-stage-mensuration-for- cascade-im/ArticleStandard/Article/detail/547892 (accessed 10 Jun 2009).
11. D Christopher P Curry W Doub, et al. 2003 Considerations for the development and practice of cascade impaction testing including a mass balance failure investigation tree J Aerosol Med 16 235 247 10.1089/089426803769017604 14572321 (Pubitemid 37169634)
12. European Directorate for the Quality of Medicines and Healthcare (EDQM). Section 2.9.18-Preparations for inhalation: aerodynamic assessment of fine particles. European Pharmacopeia 6th Edn., Strasbourg, France: Council of Europe; 2009, pp. 287-300.
13. United States Pharmacopeial Convention (USP) Chapter 601-physical tests and determinations: aerosols. Rockville, MD: USP30-NF25; 2007. pp. 220-40.
14. DL Roberts FJ Romay 2005 Relationship of stage mensuration data to the performance of new and used cascade impactors J Aerosol Med 18 396 413 10.1089/jam.2005.18.396 16379616 (Pubitemid 43038406)
15. DL Roberts 2009 Theory of multi-nozzle impactor stages and the interpretation of stage mensuration data Aerosol Sci Technol 43 11 1119 1129 10.1080/02786820903204060 1:CAS:528:DC%2BD1MXht1Ohur7O
16. Shelton CM. Comparison of optical systems for mensuration of 8-stage cascade impactor. In: Drug Delivery to the Lungs-15, London, UK: The Aerosol Society; 2004. pp. 133-6.
17. Mitchell JP. Good Practices of Qualifying Cascade Impactors (CIs): A Survey of Members of the European Pharmaceutical Aerosol Group (EPAG). Drug Delivery to the Lungs-16, London, UK: The Aerosol Society; 2005. p. 189-92.